Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 8 of 8

Full-Text Articles in Medicine and Health Sciences

Physicians' Knowledge And Attitudes Of Disordered Eating Behaviors Among Patients With Diabetes, Nayiri Khatchadourian, Lowell Schmeltz, Michael Brennan, Virginia Uhley May 2023

Physicians' Knowledge And Attitudes Of Disordered Eating Behaviors Among Patients With Diabetes, Nayiri Khatchadourian, Lowell Schmeltz, Michael Brennan, Virginia Uhley

Posters

Patients diagnosed with type 1 and type 2 Diabetes Mellitus (DM) are at increased risk for developing clinical disordered eating behaviors (DEBs). Although research supports this higher incidence and the impact on health outcomes, few studies have assessed physicians’ knowledge, attitudes and training to identify and treat these conditions. The American Diabetes Associations’ 2021 Standards of Care included a new section about DEB, further highlighting the importance of addressing this issue. Our goal was to assess physicians’ level of training, comfort and attitudes towards providing clinical care to patients diagnosed with DM and their experience in assessing, identifying, and treating …


Pasteurella Multocida Bacteremia Secondary To Multiple Cat Scratches, Charles Boadu, Andrea Hernandez, Bassem Zeidan, John T. Young, Johnathan Frunzi Jun 2020

Pasteurella Multocida Bacteremia Secondary To Multiple Cat Scratches, Charles Boadu, Andrea Hernandez, Bassem Zeidan, John T. Young, Johnathan Frunzi

West Florida Division Virtual Research Day 2020

Pasteurella multocida(P. multocida)is part of the normal gastrointestinal and upper respiratory flora of domestic and wild animals such as dogs, cats, rabbits, opossums, boars, tigers, lions and horses (1, 2). Transmission of P. multocidais usually through scratches and bites leading to infections of the soft tissue and skin (3,4). P. multocida bacteremia is rare, but occurs in individuals with major risk factors including chronic pulmonary disease, diabetes mellitus, end state renal disease (ESRD), and an immunocompromised state (3,4). Non traumatic infections of P. multocida in immunocompromised individuals,are more likely to require care in the intensive care unit …


Genetic Factors Related To The Incidence Of Type Ii Diabetes In Adults, Andrew Bader Jan 2016

Genetic Factors Related To The Incidence Of Type Ii Diabetes In Adults, Andrew Bader

Physician Assistant Scholarly Project Posters

As the seventh leading cause of death in the United States, diabetes affects 29.1 million people. In May, 2015 the U.S. CDC reported, the estimated total financial burden for diabetes in the United States at greater than $245 billion ($69 billion attributed to disability, lost days at work and premature death). The purpose of this study was to investigate genetic variances in parallel with type II diabetes. Through a five year prior search of Cochrane, Medline and Pubmed this review of the literature examined studies regarding type II diabetes related genetic variances specific to non-ethnic and ethnic populations of otherwise …


Insulin Patch Pumps In Type 2 Diabetes, Cristin Altendorf Jan 2015

Insulin Patch Pumps In Type 2 Diabetes, Cristin Altendorf

Physician Assistant Scholarly Project Posters

• DM is a leading cause of death in Americans

• A HbA1c above 6.5% is diagnostic for DM because it is at this level the patient is at risk for retinopathy and other microvascular disease

• The purpose of this study is to determine alternative methods of maintaining tighter control on HbA1c to lessen the effects of type II diabetes.


Does Pharmacogenetics Play A Role In The Treatment Of Type Ii Diabetes Mellitus?, Lucas N. Vanemelen Jan 2015

Does Pharmacogenetics Play A Role In The Treatment Of Type Ii Diabetes Mellitus?, Lucas N. Vanemelen

Physician Assistant Scholarly Project Posters

• Type 2 diabetes mellitus (T2DM) is a disease commonly presented in the family practice setting. Current therapies include one or multiple medications. Until recently, providers have used algorithms and medical expertise to control T2DM.

• Pharmacogenomics is a branch of pharmacology dealing with genetic variation on a medication response in an individual patient to discover medication compatibility, efficacy or toxicity.

• Analysis of genetic factors are still being discovered; however, this growing field may change the way medications are being prescribed for diabetes. This analysis investigated if pharmacogenetics is a useful tool for prescribing diabetic medications to T2DM patients. …


Oncolog Volume 53, Number 09, September 2008, Maude Veech, Dawn Chalaire Jan 2008

Oncolog Volume 53, Number 09, September 2008, Maude Veech, Dawn Chalaire

OncoLog MD Anderson's Report to Physicians (All issues)

  • Deciphering Metastatic Colorectal Carcinoma
  • House Call: Planning Ahead with Advance Directives
  • A Child-Centered Approach to Anesthesia for Proton Therapy


Oncolog, Volume 45, Number 12, December 2000, Sunni Hosemann, Noelle Heinze, Alison Rufffin Dec 2000

Oncolog, Volume 45, Number 12, December 2000, Sunni Hosemann, Noelle Heinze, Alison Rufffin

OncoLog MD Anderson's Report to Physicians (All issues)

  • And Cancer Too: Treating Cancer Alongside Other Conditions
  • Compass: Clinical Practice Guidelines
  • New Study Measures the Effects of Mood and Hereditary Tendencies to Smoke on Tobacco Cessation
  • House Call: How to Talk with Your Doctor
  • Controlling Infections in Patients with Neutropenia Remains a Challenge


Oncolog, Volume 40, Number 04, October-December 1995, Kathryn L. Hale, Vickie J. Williams Jan 1995

Oncolog, Volume 40, Number 04, October-December 1995, Kathryn L. Hale, Vickie J. Williams

OncoLog MD Anderson's Report to Physicians (All issues)

  • Psychiatry at M. D. Anderson: Helping patients learn to live with cancer
  • Technology and cooperation powerful tools in locating genes
  • Second opinion clinic helps patients get the best treatment